Tech Company Financing Transactions

Eureka Therapeutics Funding Round

Eureka Therapeutics, operating out of Emeryville, received $26.6 million from private investors.

Transaction Overview

Announced On
5/31/2017
Transaction Type
Venture Equity
Amount
$26,572,831
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 40 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5858 Horton St. 170
Emeryville, CA 94608
USA
Email Address
Overview
Eureka Therapeutics is focused on developing novel T cell immunotherapies for the treatment of solid tumors. Our unique platform is powered by TCR-like antibodies which recognize previously inaccessible cancer antigens specific for solid tumors.
Profile
Eureka Therapeutics LinkedIn Company Profile
Social Media
Eureka Therapeutics Company Twitter Account
Company News
Eureka Therapeutics News
Facebook
Eureka Therapeutics on Facebook
YouTube
Eureka Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Cheng Liu
  Cheng Liu LinkedIn Profile  Cheng Liu Twitter Account  Cheng Liu News  Cheng Liu on Facebook
Chief Operating Officer
Vivien Chan
  Vivien Chan LinkedIn Profile  Vivien Chan Twitter Account  Vivien Chan News  Vivien Chan on Facebook
VP - Bus. Development
Hanzhong Li
  Hanzhong Li LinkedIn Profile  Hanzhong Li Twitter Account  Hanzhong Li News  Hanzhong Li on Facebook
VP - General Counsel
Victor Shum
  Victor Shum LinkedIn Profile  Victor Shum Twitter Account  Victor Shum News  Victor Shum on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/31/2017: Epic Creations venture capital transaction
Next: 5/31/2017: TRVL venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary